Preclinical pharmacology of AZD9977: A novel mineralocorticoid receptor modulator separating organ protection from effects on electrolyte excretion-Reference-Cited by-同舟云学术

Preclinical pharmacology of AZD9977: A novel mineralocorticoid receptor modulator separating organ protection from effects on electrolyte excretion

Published:2018-02-23 Issue:2 Volume:13 Page:e0193380
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Bamberg Krister^ORCID,Johansson Ulrika,Edman Karl,William-Olsson Lena,Myhre Susanna,Gunnarsson Anders,Geschwindner Stefan,Aagaard Anna,Björnson Granqvist Anna,Jaisser Frédéric,Huang Yufeng,Granberg Kenneth L.,Jansson-Löfmark Rasmus,Hartleib-Geschwindner Judith

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference71 articles.

1. Aldosterone: its receptor, target genes, and actions;D Pearce;Vitamins and hormones,2003

2. Prerequisite for cardiac aldosterone action. Mineralocorticoid receptor and 11 beta-hydroxysteroid dehydrogenase in the human heart;M Lombes;Circulation,1995

3. Involvement of aldosterone and mineralocorticoid receptors in rat mesangial cell proliferation and deformability;A Nishiyama;Hypertension,2005

4. Podocyte as the target for aldosterone: roles of oxidative stress and Sgk1;S Shibata;Hypertension,2007

5. Aldosterone biosynthesis and action in vascular cells;R Takeda;Steroids,1995

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mineralocorticoid Antagonism in Heart Failure;JACC: Heart Failure;2024-09

2. In silico analysis of endocrine‐disrupting potential of triclosan, bisphenol A, and their analogs and derivatives;Journal of Applied Toxicology;2024-08-11

3. Mineralocorticoid receptor (MR) antagonist eplerenone and MR modulator balcinrenone prevent renal extracellular matrix remodeling and inflammation via the MR/proteoglycan/TLR4 pathway;Clinical Science;2024-08

4. Can the novel aldosterone inhibiting drug balcinrenone reduce hyperkalaemia and worsening renal function compared to steroidal mineralocorticoid receptor antagonists in heart failure?;European Journal of Heart Failure;2024-07-22

5. Balcinrenone plus dapagliflozin in patients with heart failure and chronic kidney disease: Results from the phase 2b MIRACLE trial;European Journal of Heart Failure;2024-05-23